ClinicalTrials.gg
RecruitingNCT07396532Updated Feb 9, 2026

Audio-Recorded Messages Delivered Via iPad to Prevent Delirium in Hip Fracture Patients

An interventional study of Audio-Recorded Reorientation Intervention in Delirium - Postoperative, Delirium and Post-operative Cognitive Dysfunction (POCD) and Delirium, Postoperative, sponsored by Sengkang General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by Sengkang General Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Emergence Delirium with a site in Singapore — 3 open to participants now, 3 under way, none of them phase 3. Emergence Delirium · Singapore.

Started
2025
the only one that year
No phase
4 of 10
2 open now
Registered
10th of 10
by date
Lead sponsor
1 of 10
Sengkang General Hospital

Among the 10 studies in Emergence Delirium with a site in Singapore, this one is the only one that started in 2025, is one of 4 with no phase, and was the 10th registered.

Emergence Delirium

753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

3 of the 10 studies in Emergence Delirium with a site in Singapore are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Emergence Delirium with a site in Singapore, or all of them as a file.
02

Study summary

The goal of this pilot clinical trial is to learn if personalized audio-recorded reorientation messages can be successfully implemented in general hospital wards for elderly patients after hip fracture surgery. It will also explore whether this intervention might help prevent confusion (delirium) after surgery. The main questions it aims to answer are:

  • Can the intervention be successfully delivered by nursing staff in a busy orthopedic ward?
  • How many eligible patients can be recruited and retained in the study?
  • Do patients tolerate listening to the personalized audio messages without problems?
  • Does listening to personalized audio messages show any early signs of reducing confusion after surgery?

Researchers will compare patients who receive personalized audio messages to those who receive usual care to see if the intervention is feasible to implement and whether it shows promise for preventing delirium.

Participants will:

  • Listen to 2-minute personalized audio-recorded reorientation messages played through an iPad and headphones three times daily for the first 3 days after surgery
  • Have their orientation and mental status checked daily for three times by nursing staff
  • Continue with all their regular medical care and treatments
  • Be monitored until discharge from the study wards.
Read the detailed description

Background and Rationale:

Hip fracture surgery is common among elderly patients, but recovery can be complicated by post-operative delirium (confusion), which affects up to 50% of patients and can lead to longer hospital stays, increased complications, and delayed rehabilitation. Non-pharmacological interventions, particularly reorientation strategies, have shown promise in preventing delirium, but implementation in busy hospital wards remains challenging.

Study Design and Innovation:

This pilot randomized controlled trial tests an innovative approach using personalized audio-recorded reorientation messages delivered via 'Shortcut' Application on the iPad technology. The messages are available in multiple languages (English, Mandarin, Malay, Tamil) to accommodate the diverse patient population, but the content is standardized across all participants. This technology-supported approach enables nurses to provide systematic reorientation interventions as part of their routine care.

Intervention Details:

The audio messages are approximately 2 minutes long and include: reorientation information (patient's location, real-time update of date and time, reason for admission), explanation of their recovery process, encouragement for therapy participation, pain management guidance, and reassuring messages on who are taking care of them in the hospital. Messages are played through noise-canceling headphones to ensure clarity and minimize ward noise interference.

Implementation Approach:

Nursing staff receive brief training on the iPad system and the workflow process. The intervention is designed to be sustainable within existing workflow patterns without adding significant burden to clinical staff. Visual reminders of workflow process were also readily available in nursing stations to remind the nurses. Study team also do their rounds to ensure availability of equipment and to clarify doubts from nursing staff.

Target Population:

Elderly patients (≥60 years) admitted to orthopedic wards following hip fracture surgery who are at risk for developing post-operative delirium based on established risk factors.

Feasibility Focus:

As a pilot study, this research prioritizes understanding implementation challenges, staff acceptance, patient tolerance, and recruitment feasibility to inform the design of a future definitive trial examining delirium prevention effectiveness.

03

Conditions studied

  • Delirium - Postoperative
  • Delirium and Post-operative Cognitive Dysfunction (POCD)
  • Delirium, Postoperative

Keywords

  • delirium
  • nurse-led
  • reality reorientation
  • AI
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults aged 60 years and above
  • Undergoing hip fracture repair surgery
  • No history of cognitive impairment as assessed by Abbreviated Mental Test (AMT)
  • Able to understand to any of the basic languages of Singapore (English, Malay, Mandarin, Tamil)

Exclusion criteria

Exclusion Criteria:

  • Patients not admitted directly to orthopaedic (study) wards post-operation (such as those requiring post-operative high-dependency unit care)
  • Patients managed conservatively without surgical intervention.
  • Patients admitted for periprosthetic hip fracture repairs
  • Patients who are deaf and mute
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Audio-Recorded Reorientation Intervention

    Participants in this arm receive personalized audio-recorded reorientation messages delivered three times daily during the first three post-operative days. Each message lasts approximately 2 minutes and contains personalized information including the current location, date and time, and encouraging messages. Messages are delivered via iPad and headphones by nursing staff during routine care. Audio messages are available in English, Mandarin, Malay, and Tamil to accommodate patient language preferences. Participants also receive all standard post-operative care and treatments.

    Behavioral: Audio-Recorded Reorientation Intervention

  • No intervention
    Standard Care Control

    Participants in this arm receive standard hip fracture care according to the hospital's established hip fracture pathway. Standard care includes early mobilization with sitting out of bed three times daily, allied health professional involvement (physiotherapist, occupational therapist, and dietitian), and routine orientation assessment. Participants found to be disoriented are screened for delirium using the validated 4AT assessment tool administered by nursing staff. Those identified as at-risk or experiencing delirium receive a comprehensive delirium care bundle including environmental modifications, medication review, and enhanced monitoring. Standard reorientation interventions include whiteboard orientation displays and purple wrist tags for participants at risk of cognitive impairment to ensure enhanced monitoring and fall prevention. No study-specific interventions are provided to this group beyond routine hospital care protocols.

Interventions

  • BehavioralAudio-Recorded Reorientation Intervention

    Participants in this arm receive personalized audio-recorded reorientation messages delivered three times daily during the first three post-operative days. Each message lasts approximately 2 minutes and contains personalized information including the current location, date and time, and encouraging messages. Messages are delivered via iPad and headphones by nursing staff during routine care. Audio messages are available in English, Mandarin, Malay, and Tamil to accommodate patient language preferences. Participants also receive all standard post-operative care and treatments.

06

What researchers measure

Primary outcomes

  1. Protocol Adherence Rate

    Percentage of planned audio-recorded reorientation sessions successfully delivered by the nurses across the first 3-day intervention period. Target adherence rate ≥95% to demonstrate intervention feasibility.

    Time frame: Postoperative day 1 to postoperative day 3

  2. Recruitment Feasibility

    Recruitment feasibility measured by screening-to-enrollment rate, calculated as: (1) percentage of screened patients meeting eligibility criteria, and (2) percentage of eligible patients providing informed consent. These rates will be tracked throughout the study period to assess the feasibility of recruiting the target population for a future definitive trial. Target enrollment rate of ≥80% of eligible patients will indicate feasibility.

    Time frame: From enrollment to end of study participation (up to 2 weeks)

  3. Study Retention Rate

    Percentage of enrolled participants who completed the study protocol without withdrawal, calculated as number completing study divided by total enrolled. Target retention rate ≥90% to demonstrate intervention feasibility.

    Time frame: From enrollment to end of study participation (up to 2 weeks)

  4. Intervention Tolerance Rate

    Completion of each audio-recorded reorientation session without early discontinuation or adverse reactions, assessed during each of the 9 planned sessions per participant. Target adherence rate ≥95% to demonstrate intervention feasibility.

    Time frame: Postoperative Day 1 to Postoperative Day 3

Secondary outcomes

  1. Number of participants with delirium as assessed by 4AT (4 'A's Test) screening tool

    Delirium will be assessed using the 4AT (4 'A's Test), a validated 4-item screening instrument that evaluates alertness, attention (months backwards), acute change or fluctuating course, and AMT4 (age, date of birth, place, current year). The 4AT score ranges from 0-12, with scores ≥4 indicating possible delirium and scores ≥1 suggesting cognitive impairment. Delirium incidence will be reported as the number and percentage of participants who score ≥4 on the 4AT during their study participation period.

    Time frame: From postoperative day 1 to end of study participation (up to 2 weeks)

  2. Length of stay in study ward measured in days

    Length of stay will be measured as the total number of days from admission to the pilot ward until discharge from the pilot ward (either to home, transfer to another ward, or transfer to community hospital). This measure captures only the time spent specifically in the study/pilot ward and does not include any subsequent stays in other wards or facilities. Length of stay will be calculated in whole days and reported as mean, median, and range.

    Time frame: From admission to pilot ward until discharge/transfer from pilot ward (up to 2 weeks)

  3. Number of participants actively participating in prescribed physiotherapy and occupational therapy sessions

    Allied health participation will be measured as the number and percentage of participants who actively engage in their prescribed physiotherapy (PT) and occupational therapy (OT) sessions during their stay in the pilot ward. Participation will be defined as attending and actively engaging in therapy sessions as documented by the treating therapists. Since all hip fracture patients receive standard PT/OT orders, this outcome measures engagement rather than referral rates. Data will be collected through therapy documentation review.

    Time frame: From postoperative day 1 to postoperative day 3

  4. Cumulative analgesic consumption

    Analgesic consumption will be measured as the total cumulative dose of commonly prescribed analgesics (morphine, paracetamol, and oxycodone) consumed by participants during post-operative days 1 to 3. All doses will be recorded in their respective units (morphine in mg, paracetamol in mg, oxycodone in mg) from medication administration records. This outcome assesses whether improved orientation and medication compliance messaging through the audio-recorded intervention affects analgesic usage patterns. Data will include both scheduled and PRN (as needed) doses administered.

    Time frame: From postoperative day 1 to postoperative day 3

07

Study locations

1 of 1 sites recruiting
  • Sengkang General Hospital
    Singapore, 544886, Singapore
    Recruiting
    • Elaine Goh, RN, BSN · Contactelaine.goh.sh@skh.com.sg · +65 82288624
    • Elaine Goh, RN, BSN · Principal investigator
    • Sandy Ang, RN, BSN · Sub investigator
    • Hui Yu Pang, RN, BSN · Sub investigator
    • Di Zhang, RN, DNP · Sub investigator
    • Yoke Hui Wong, RN, DNP · Sub investigator
08

References and documents

Publications

  • Munro CL, Cairns P, Ji M, Calero K, Anderson WM, Liang Z. Delirium prevention in critically ill adults through an automated reorientation intervention - A pilot randomized controlled trial. Heart Lung. 2017 Jul-Aug;46(4):234-238. doi: 10.1016/j.hrtlng.2017.05.002. Epub 2017 Jun 9. PubMed 28606450 ↗
  • Kasapoglu ES, Enc N. Role of multicomponent non-pharmacological nursing interventions on delirium prevention: A randomized controlled study. Geriatr Nurs. 2022 Mar-Apr;44:207-214. doi: 10.1016/j.gerinurse.2022.02.015. Epub 2022 Feb 26. PubMed 35227973 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to the pilot nature of this feasibility study with a small sample size. Aggregate results and study findings will be made available through peer-reviewed publications and conference presentations. The study protocol and statistical analysis plan will be made publicly available.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for May 2026, 8 months after the start.

Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 8 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2025
First posted
Feb 9, 2026
StartActual
Sep 29, 2025
Primary completionEst.
May 2026
CompletionEst.
Jul 2026
Last update
Feb 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07396532
Lead sponsor
Sengkang General Hospital
Responsible party
Sponsor
First posted
Feb 9, 2026
Start date
Sep 29, 2025
Primary completion
May 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Feb 9, 2026

Study contacts

Elaine Goh, RN, BSN
Contact
elaine.goh.sh@skh.com.sg
+65 82288624

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion